Abivax S.A. ABVX · SEC Filings

website

Abivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the dis...

Price87

Market Cap7.62 B

Float79.31 M

CountryFR

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 23, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 24, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 5, 2024

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Jul 2, 2026

424B5

PENDING FIXED PRICE OFFERING | Offering amount: $600,000,000 | Bank: Leerink Partners, Morgan Stanley, Piper Sandler, Guggenheim Securities

Jun 30, 2026

424B7

Form 424B7 - Prospectus [Rule 424(b)(7)]

May 7, 2026

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Jul 24, 2025

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Jul 23, 2025

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Oct 23, 2023

Registrations

TYPE

HEADLINE

FILED AT

F-6EF

Form F-6EF - Registration of American Depository Receipt shares, immediately effective

Sep 21, 2026

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Jul 1, 2026

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Jun 30, 2026

POSASR

Form POSASR - Post-effective Amendment to an automatic shelf registration statement

Jun 30, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 23, 2026

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Jul 24, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Nov 27, 2024

CORRESP

Form CORRESP - Correspondence

Nov 25, 2024

LETTER

Form UPLOAD - SEC-generated letter

Nov 22, 2024

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 20, 2023

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 20, 2023

CORRESP

Form CORRESP - Correspondence

Oct 18, 2023